Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Amgen USD 24.96B 534M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
aTyr Pharma USD 11.7M 101.49M 2026-03
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Curis USD 14.08M 5.3M 2025-12
Sanofi EUR 28.35B 9.32B 2025-12
TG Therapeutics USD 187.11M 33.35M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Xoma USD 28.3M 6.81M 2025-09